Lv74
5008 积分 2021-08-24 加入
First-line pyrotinib in advanced HER2-mutant non-small-cell lung cancer: a patient-centric phase 2 trial
2天前
已完结
Combined radiation- and immune checkpoint-inhibitor-induced pneumonitis - The challenge to predict and detect overlapping immune-related adverse effects from evolving laboratory biomarkers and clinical imaging
24天前
已关闭
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update
24天前
已完结
Recent advances in the study of immune checkpoint inhibitor-associated pneumonia
24天前
已完结
Precise regulation of cancer vaccine and immune checkpoint inhibitor synergy potentiates immunotherapy with reduced immune-related pneumonitis
25天前
已关闭
Clinical management of checkpoint inhibitor pneumonitis: Focus, challenges, and future directions
25天前
已关闭
Association Between Toxic Effects and Survival in Patients With Cancer and Autoimmune Disease Treated With Checkpoint Inhibitor Immunotherapy
25天前
已完结
Multi-organ immune-related adverse events from immune checkpoint inhibitors and their downstream implications: a retrospective multicohort study
25天前
已完结
Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy
25天前
已完结
皖公网安备34019202002308
